These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9462614)

  • 41. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left ventricular hypertrophy and its regression in essential arterial hypertension. A tissue Doppler imaging study.
    Di Bello V; Giorgi D; Pedrinelli R; Talini E; Palagi C; Delle Donne MG; Zucchelli G; Dell'omo G; Di Cori A; Dell'Anna R; Caravelli P; Mariani M
    Am J Hypertens; 2004 Oct; 17(10):882-90. PubMed ID: 15485749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cardiopulmonary reflexes of spontaneously hypertensive rats are normalized after regression of left ventricular hypertrophy and hypertension.
    Uggere TA; Abreu GR; Sampaio KN; Cabral AM; Bissoli NS
    Braz J Med Biol Res; 2000 May; 33(5):589-94. PubMed ID: 10775891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.
    Clement DL; De Buyzere M; Duprez D
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):14S-19S. PubMed ID: 8466720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of enalapril on left ventricular hypertrophy in patients with mild or moderate essential hypertension].
    Batlouni M; Armaganijan D; Assef JE
    Arq Bras Cardiol; 1990 May; 54(5):347-50. PubMed ID: 2149633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols].
    González-Juanatey JR; Amaro Cendón A; Calvo Gómez C; Vega Fernández M; García Acuña JM; Virgós Lamela A; Gil de la Peña M
    Med Clin (Barc); 1992 Mar; 98(11):401-4. PubMed ID: 1533259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
    Galderisi M; D'Errico A; Sidiropulos M; Innelli P; de Divitiis O; de Simone G
    J Hypertens; 2009 Oct; 27(10):2108-15. PubMed ID: 19564794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.
    Schrier R; McFann K; Johnson A; Chapman A; Edelstein C; Brosnahan G; Ecder T; Tison L
    J Am Soc Nephrol; 2002 Jul; 13(7):1733-9. PubMed ID: 12089368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril.
    González-Juanatey JR; García-Acuña JM; Pose A; Varela A; Calvo C; Cabezas-Cerrato J; de la Peña MG
    Am J Cardiol; 1998 Jan; 81(2):170-4. PubMed ID: 9591900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical importance of detecting exaggerated blood pressure response to exercise on antihypertensive therapy.
    Mizuno R; Fujimoto S; Saito Y; Yamazaki M
    Heart; 2016 Jun; 102(11):849-54. PubMed ID: 26839069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise tolerance.
    Leonetti G; Fogari R; Mazzola C; Pasotti C; Ponti GB; Marelli C; Zanchetti A
    J Hypertens Suppl; 1993 Dec; 11(5):S356-7. PubMed ID: 8158420
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of ACE inhibition on left ventricular dimensions and haemodynamics in systemic hypertension: a radionuclide and echocardiographic study.
    Haznedaroglu IC; Erdem Y; Tokgözoglu L; Caglar M; Kes S; Sayinalp NM; Yörükan S
    Cent Afr J Med; 1995 Apr; 41(4):118-23. PubMed ID: 7788682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the efficacy and tolerance of doxazosin vs. enalapril inaged patients with light to moderate arterial hypertension].
    Puddu P; Gallucci M; Curnis A; Pupita F; Ansuini R; Malacco E
    Clin Ter; 1995 Dec; 146(12):801-10. PubMed ID: 8681500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
    Pierdomenico SD; Lapenna D; Cuccurullo F
    Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
    Havranek EP; Esler A; Estacio RO; Mehler PS; Schrier RW;
    Am Heart J; 2003 Jun; 145(6):993-8. PubMed ID: 12796754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome.
    Lind L; Andersson PE; Andrén B; Hänni A; Lithell HO
    J Hypertens; 1995 Apr; 13(4):433-8. PubMed ID: 7629404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypertension and left ventricular hypertrophy: what is the link?
    Arthur A; McNulty CM
    R I Med; 1993 May; 76(5):245-8. PubMed ID: 8518500
    [No Abstract]   [Full Text] [Related]  

  • 58. Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension.
    Nishikimi T; Matsuoka H; Ishikawa K; Yoshihara F; Kawano Y; Kitamura K; Saito Y; Kangawa K; Matsuo H; Omae T
    Hypertens Res; 1996 Jun; 19(2):97-101. PubMed ID: 10968202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood pressure variability in controlled and uncontrolled blood pressure and its association with left ventricular hypertrophy and diastolic function.
    Wittke EI; Fuchs SC; Moreira LB; Foppa M; Fuchs FD; Gus M
    J Hum Hypertens; 2016 Aug; 30(8):483-7. PubMed ID: 26467817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.